Inventor
KOIS ADAM
US21 patents
⚠️ This page may combine multiple inventors who share the name “KOIS ADAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEXAS BIOTECHNOLOGY CORP
10 patentsUS5962490AOct 5, 1999
Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP93 citations96
US5571821ANov 5, 1996
Sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP125 citations96
US5977117ANov 2, 1999
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP72 citations95
US5594021AJan 14, 1997
Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP88 citations95
US5591761AJan 7, 1997
Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP67 citations95
US6376523B1Apr 23, 2002
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP19 citations92
US6331637B1Dec 18, 2001
N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP26 citations92
US6265428B1Jul 24, 2001
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP34 citations92
US6030991AFeb 29, 2000
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP47 citations92
US6342610B2Jan 29, 2002
N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP18 citations83
SIGNAL PHARM LLC
4 patentsUS7723340B2May 25, 2010
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC46 citations91
US7521446B2Apr 21, 2009
Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC39 citations91
US7122544B2Oct 17, 2006
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
SIGNAL PHARM LLC20 citations90
US7442699B2Oct 28, 2008
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
SIGNAL PHARM LLC10 citations82
IMMUNOPHARMACEUTICS INC
2 patentsUS5514691AMay 7, 1996
N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
IMMUNOPHARMACEUTICS INC128 citations95
US5464853ANov 7, 1995
N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
IMMUNOPHARMACEUTICS INC100 citations93